Stay updated with breaking news from Codexis Daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
HC Wainwright lowered shares of Codexis (NASDAQ:CDXS – Get Rating) from a buy rating to a neutral rating in a report issued on Tuesday morning, Marketbeat reports. HC Wainwright also issued estimates for Codexis’ FY2023 earnings at ($1.10) EPS, Q1 2024 earnings at ($0.27) EPS, Q2 2024 earnings at ($0.27) EPS, Q3 2024 earnings at […]
Codexis, Inc. (NASDAQ:CDXS – Get Rating) – Research analysts at HC Wainwright dropped their FY2023 earnings per share (EPS) estimates for Codexis in a research report issued on Tuesday, May 9th. HC Wainwright analyst S. Ramakanth now expects that the biotechnology company will post earnings per share of ($1.10) for the year, down from their […]
Codexis (NASDAQ:CDXS – Get Rating) released its quarterly earnings data on Thursday. The biotechnology company reported ($0.34) earnings per share for the quarter, missing the consensus estimate of ($0.29) by ($0.05), Briefing.com reports. Codexis had a negative return on equity of 31.32% and a negative net margin of 41.17%. The business had revenue of $12.98 […]
Codexis (NASDAQ:CDXS – Get Rating) announced its quarterly earnings results on Thursday. The biotechnology company reported ($0.34) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.29) by ($0.05), Briefing.com reports. Codexis had a negative net margin of 24.24% and a negative return on equity of 21.78%. The firm had revenue of […]
Codexis (NASDAQ:CDXS – Get Rating) released its quarterly earnings results on Thursday. The biotechnology company reported ($0.34) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.29) by ($0.05), Briefing.com reports. The firm had revenue of $12.98 million during the quarter, compared to analyst estimates of $14.09 million. Codexis had a negative return […]